Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: Implications for cancer immunotherapy protocols

Molecular Therapy

Volumn 10, Issue 4, 2004, Pages 768-779

  Dullaers, Melissa ^a   Breckpot, Karine ^a   Van Meirvenne, Sonja ^a   Bonehill, Aude ^a   Tuyaerts, Sandra ^a   Michiels, Annelies ^a   Straetman, Lieven ^a   Heirman, Carlo ^a   De Greef, Catherine ^a   Van Der Bruggen, Pierre ^b   Thielemans, Kris ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

Antigen presentation; Dendritic cell; IL 12; Immunotherapy; Lentivirus; mRNA electroporation

Indexed keywords

INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TUMOR ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LENTIVIRINAE; MOUSE; NONHUMAN; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CANCER VACCINES; CELL LINE; CELL TRANSPLANTATION; CYTOKINES; DENDRITIC CELLS; ELECTROPORATION; FEMALE; GREEN FLUORESCENT PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LENTIVIRUS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASMS; RECEPTOR, NERVE GROWTH FACTOR; RNA, MESSENGER; TRANSDUCTION, GENETIC;

LENTIVIRUS; MURINAE;

EID: 4644275422     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.07.017     Document Type: Article

References (56)

1. J. Banchereau et al. Immunobiology of dendritic cells Annu. Rev. Immunol. 18 2000 767-811
2. J. Banchereau R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245-252
3. B. Thurner et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application J. Immunol. Methods 223 1999 1-15
4. H. Rouard et al. Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity J. Immunol. Methods. 241 2000 69-81
5. Y. Suen et al. Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC Cytotherapy 3 2001 365-375
6. S. Tuyaerts et al. Generation of large numbers of dendritic cells in a closed system using cell factories J. Immunol. Methods. 264 2002 135-151
7. F.J. Hsu et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat. Med. 2 1996 52-58
8. F.O. Nestle et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nat. Med. 4 1998 328-332
9. J.M. Timmerman R. Levy Dendritic cell vaccines for cancer immunotherapy Annu. Rev. Med.. 50 1999 507-529
10. A. Marten et al. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial Cancer Immunol. Immunother. 51 2002 637-644
11. S.W. Krause et al. The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells J. Immunother. 25 2002 421-428
12. S. Sanderson K. Frauwirth N. Shastri Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins Proc. Natl. Acad. Sci. USA 92 1995 7217-7221
13. T.C. Wu et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens Proc. Natl. Acad. Sci. USA 92 1995 11671-11675
14. A.B. Dietz S. Vuk-Pavlovic High efficiency adenovirus-mediated gene transfer to human dendritic cells Blood 91 1998 392-398
15. J.F. Arthur et al. A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther. 4 1997 17-25
16. S. Ponnazhagan D.T. Curiel D.R. Shaw R.D. Alvarez G.P. Siegal Adeno-associated virus for cancer gene therapy Cancer Res. 61 2001 6313-6321
17. M.E. Reeves R.E. Royal J.S. Lam S.A. Rosenberg P. Hwu Retroviral transduction of human dendritic cells with a tumor-associated antigen gene Cancer Res. 56 1996 5672-5677
18. + T cell help to elicit protective and therapeutic antitumor immunity J. Immunol. 162 1999 144-151
19. M. Di Nicola et al. Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial Hum. Gene Ther. 14 2003 1347-1360
20. M. Di Nicola et al. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors Cancer Gene Ther. 5 1998 350-356
21. N. Chinnasamy et al. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors Hum. Gene Ther. 11 2000 1901-1909
22. A. Gruber J. Kan-Mitchell K.L. Kuhen T. Mukai F. Wong-Staal Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro Blood 96 2000 1327-1333
23. R. Schroers et al. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system Mol. Ther. 1 2000 171-179
24. K. Breckpot et al. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy J. Gene Med. 5 2003 654-667
25. J. Dyall J.B. Latouche S. Schnell M. Sadelain Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes Blood 97 2001 114-121
26. C. Esslinger P. Romero H.R. MacDonald Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors Hum. Gene Ther. 13 2002 1091-1100
27. H. Firat et al. Use of a lentiviral flap vector for induction of CTL immunity against melanoma: perspectives for immunotherapy J. Gene Med. 4 2002 38-45
28. R. Zufferey D. Nagy R.J. Mandel L. Naldini D. Trono Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat. Biotechnol. 15 1997 871-875
29. T. Dull et al. A third-generation lentivirus vector with a conditional packaging system J. Virol. 72 1998 8463-8471
30. H. Miyoshi U. Blomer M. Takahashi F.H. Gage I.M. Verma Development of a self-inactivating lentivirus vector J. Virol. 72 1998 8150-8157
31. R. Zufferey J.E. Donello D. Trono T.J. Hope Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors J. Virol. 73 1999 2886-2892
32. D. Chinnasamy et al. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins Blood 96 2000 1309-1316
33. A. Follenzi L.E. Ailles S. Bakovic M. Geuna L. Naldini Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences Nat. Genet. 25 2000 217-222
34. V. Zennou et al. HIV-1 genome nuclear import is mediated by a central DNA flap Cell 101 2000 173-185
35. V.F. VanTendeloo et al. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells Gene Ther. 5 1998 700-707
36. V.F. VanTendeloo et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells Blood 98 2001 49-56
37. S.K. Nair et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA Nat. Biotechnol. 16 1998 364-369
38. P. Ponsaerts et al. mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation Leukemia 16 2002 1324-1330
39. A. Lundqvist et al. Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection J. Immunother. 25 2002 445-454
40. S. VanMeirvenne Efficient genetic modification of murine dendritic cells by electroporation with mRNA Cancer Gene Ther. 9 2002 787-797
41. S. Tuyaerts et al. Induction of influenza matrix protein 1 and melanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells Cancer Gene Ther. 10 2003 696-706
42. + cytolytic T lymphocytes Cancer Res. 60 2000 6272-6275
43. E.S. Schultz et al. A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes Tissue Antigens. 57 2001 103-109
44. D. Chassin et al. Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects Eur. J. Immunol. 29 1999 196-202
45. + T lymphocytes AIDS Res. Hum. Retroviruses 17 2001 1365-1370
46. H.F. Gallardo C. Tan D. Ory M. Sadelain Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes Blood 90 1997 952-957
47. M.L. Liu B.L. Winther M.A. Kay Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer J. Virol. 70 1996 2497-2502
48. M. Chalfie Y. Tu G. Euskirchen W.W. Ward D.C. Prasher Green fluorescent protein as a marker for gene expression Science 263 1994 802-805
49. P. Corish C. Tyler-Smith Attenuation of green fluorescent protein half-life in mammalian cells Protein Eng. 12 1999 1035-1040
50. M.L. Schmitz S. Bacher O. Dienz NF-kappaB activation pathways induced by T cell costimulation 17 2003 2187-2193
51. H. Rouard et al. IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells J. Immunother. 25 2002 324-333
52. + T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma J. Immunol. 170 2003 400-412
53. S.W. Lee Y. Park J.K. Yoo S.Y. Choi Y.C. Sung Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12 J. Immunol. 170 2003 2456-2460
54. F. Granucci C. Vizzardelli E. Virzi M. Rescigno P. Ricciardi-Castagnoli Transcriptional reprogramming of dendritic cells by differentiation stimuli Eur. J. Immunol. 31 2001 2539-2546
55. Breckpot A. et al. Activation of monocytes via the CD14 receptor leads to the enhanced lentiviral transduction of immature dendritic cells Hum. Gene Ther. 15 2004 562-573
56. Kuipers J. et al. Leuk. Biol. 2004 in press